Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01246986
Title A Study of LY2157299 in Participants With Hepatocellular Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

hepatocellular carcinoma

Therapies

Galunisertib + Sorafenib

Galunisertib

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.